REPHA GmbH Biologische Arzneimittel
REPHA GmbH Biologische Arzneimittel is a Private limited company (Ltd.) registered in Germany under HRB 1257 Hannover, and its current status with Handelsregister (Commercial Register) is active. Its registered address on file is Langenhagen, Germany. 5 shareholders are on record for REPHA GmbH Biologische Arzneimittel, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 16 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for REPHA GmbH Biologische Arzneimittel, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG.
The largest of these is Bradtmöller GmbH & Co. KG, holding 52% — a majority holding — followed by Bradtmöller GmbH & Co. KG at 20%; the remaining 3 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Bradtmöller GmbH & Co. KG | 52% | Handelsregister (Commercial Register) | |
| Bradtmöller GmbH & Co. KG | 20% | Handelsregister (Commercial Register) | |
| Bradtmöller GmbH & Co. KG | 12% | Handelsregister (Commercial Register) | |
| Bradtmöller GmbH & Co. KG | 12% | Handelsregister (Commercial Register) | |
| Bradtmöller GmbH & Co. KG | 4% | Handelsregister (Commercial Register) |
Officers
4
Three of the 4 officer records shown for REPHA GmbH Biologische Arzneimittel are current appointments, filed with Handelsregister (Commercial Register). Björn Bradtmöller serves as Geschäftsführer (managing director); Ole Goos (appointed 2018-12-20) and Michael Köller (appointed 2018-12-20) both serve as Officer. The remaining 1 record shown (Gunter Köller) is a former appointment that has since been resigned.
Management authority at REPHA GmbH Biologische Arzneimittel sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
REPHA GmbH Biologische Arzneimittel sits 1 level below its ultimate parent, Bradtmöller GmbH & Co. KG, registered in Germany. Immediately above REPHA GmbH Biologische Arzneimittel is Bradtmöller GmbH & Co. KG, holding 100% as filed in REPHA GmbH Biologische Arzneimittel's own shareholder record with Handelsregister (Commercial Register).
Bradtmöller GmbH & Co. KG
Germany
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns REPHA GmbH Biologische Arzneimittel?
Five shareholders are currently on record for REPHA GmbH Biologische Arzneimittel, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG. The largest of these is Bradtmöller GmbH & Co. KG, holding 52% — a majority holding — followed by Bradtmöller GmbH & Co. KG at 20%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is REPHA GmbH Biologische Arzneimittel's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for REPHA GmbH Biologische Arzneimittel is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does REPHA GmbH Biologische Arzneimittel have on record?
5 shareholders are shown on record for REPHA GmbH Biologische Arzneimittel.
What is REPHA GmbH Biologische Arzneimittel's company registration number?
REPHA GmbH Biologische Arzneimittel's registration number is HRB 1257 Hannover, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is REPHA GmbH Biologische Arzneimittel still an active company?
REPHA GmbH Biologische Arzneimittel's status on Handelsregister (Commercial Register) is listed as active.
What is REPHA GmbH Biologische Arzneimittel's registered address?
The registered address on file for REPHA GmbH Biologische Arzneimittel is Langenhagen, Germany.
Who are the officers/directors of REPHA GmbH Biologische Arzneimittel?
Three of the 4 officer records shown for REPHA GmbH Biologische Arzneimittel are current appointments, filed with Handelsregister (Commercial Register). Björn Bradtmöller serves as Geschäftsführer (managing director); Ole Goos (appointed 2018-12-20) and Michael Köller (appointed 2018-12-20) both serve as Officer. The remaining 1 record shown (Gunter Köller) is a former appointment that has since been resigned. Management authority at REPHA GmbH Biologische Arzneimittel sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does REPHA GmbH Biologische Arzneimittel have a parent company or subsidiaries?
REPHA GmbH Biologische Arzneimittel sits 1 level below its ultimate parent, Bradtmöller GmbH & Co. KG, registered in Germany.
Can Zavia monitor changes to REPHA GmbH Biologische Arzneimittel's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to REPHA GmbH Biologische Arzneimittel's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access REPHA GmbH Biologische Arzneimittel's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like REPHA GmbH Biologische Arzneimittel's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 16 October 2026.